Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Cancer Science|June 18, 2019
Immunohistological analysis of pancreatic carcinoma after vaccination with survivin 2B peptide: Analysis of an autopsy seriesTerufumi Kubo, Giichiro Tsurita, Yoshihiko Hirohashi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 18, 2009
Cep55/c10orf3, a tumor antigen derived from a centrosome residing protein in breast carcinomaSatoko Inoda, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2019
Peptide vaccinations elicited strong immune responses that were reboosted by anti-PD1 therapy in a patient with myxofibrosarcomaTomohide Tsukahara, Kazue Watanabe, Kenji Murata, et al.
Cancer Immunology, Immunotherapy : CII|February 16, 2023
Cisplatin resistance driver claspin is a target for immunotherapy in urothelial carcinomaShuhei Yamada, Haruka Miyata, Makoto Isono, et al.
Nature Biotechnology|March 2, 2021
Affinity-matured HLA class II dimers for robust staining of antigen-specific CD4+ T cellsKenji Sugata, Yukiko Matsunaga, Yuki Yamashita, et al.
Oncotarget|July 16, 2016
Plasticity of lung cancer stem-like cells is regulated by the transcription factor HOXA5 that is induced by oxidative stressHiroshi Saijo, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.
Cancer Science|June 21, 2019
Randomized phase II trial of survivin 2B peptide vaccination for patients with HLA-A24-positive pancreatic adenocarcinomaHiroaki Shima, Giichiro Tsurita, Satoshi Wada, et al.
Elife|April 22, 2020
Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanomaKenji Murata, Munehide Nakatsugawa, Muhammed A Rahman, et al.
Pageof 9